The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
The process of supplying EPO externally, usually with the help of recombinant DNA technology in a cell culture, is known as rhEPO. rhEPO is used to treat anemia due to neural diseases, injuries, kidney diseases or cancer.
The global rhEPO market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for rhEPO is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for rhEPO is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of rhEPO include 3SBio, Shanghai Chemo, Chengdu Diao, NCPC Genetech, Kyowa Hakko Kirin, Shandong Kexing, Ahua Pharmaceutical, Biosidus and Dragon Pharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for rhEPO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding rhEPO.
Report Scope
The rhEPO market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global rhEPO market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the rhEPO manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
3SBio
Shanghai Chemo
Chengdu Diao
NCPC Genetech
Kyowa Hakko Kirin
Shandong Kexing
Ahua Pharmaceutical
Biosidus
Dragon Pharma
Segment by Type
ESRD
Cancer
HIV
Wounds and neural disease
Segment by Application
Hospitals
Retail Pharmacies
Consumption by Region
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of rhEPO manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of rhEPO in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The process of supplying EPO externally, usually with the help of recombinant DNA technology in a cell culture, is known as rhEPO. rhEPO is used to treat anemia due to neural diseases, injuries, kidney diseases or cancer.
The global rhEPO market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for rhEPO is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for rhEPO is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of rhEPO include 3SBio, Shanghai Chemo, Chengdu Diao, NCPC Genetech, Kyowa Hakko Kirin, Shandong Kexing, Ahua Pharmaceutical, Biosidus and Dragon Pharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for rhEPO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding rhEPO.
Report Scope
The rhEPO market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global rhEPO market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the rhEPO manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
3SBio
Shanghai Chemo
Chengdu Diao
NCPC Genetech
Kyowa Hakko Kirin
Shandong Kexing
Ahua Pharmaceutical
Biosidus
Dragon Pharma
Segment by Type
ESRD
Cancer
HIV
Wounds and neural disease
Segment by Application
Hospitals
Retail Pharmacies
Consumption by Region
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of rhEPO manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of rhEPO in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 rhEPO Market Overview
1.1 Product Overview and Scope of rhEPO
1.2 rhEPO Segment by Type
1.2.1 Global rhEPO Market Value Comparison by Type (2024-2030)
1.2.2 ESRD
1.2.3 Cancer
1.2.4 HIV
1.2.5 Wounds and neural disease
1.3 rhEPO Segment by Application
1.3.1 Global rhEPO Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Retail Pharmacies
1.4 Global rhEPO Market Size Estimates and Forecasts
1.4.1 Global rhEPO Revenue 2019-2030
1.4.2 Global rhEPO Sales 2019-2030
1.4.3 Global rhEPO Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 rhEPO Market Competition by Manufacturers
2.1 Global rhEPO Sales Market Share by Manufacturers (2019-2024)
2.2 Global rhEPO Revenue Market Share by Manufacturers (2019-2024)
2.3 Global rhEPO Average Price by Manufacturers (2019-2024)
2.4 Global rhEPO Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of rhEPO, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of rhEPO, Product Type & Application
2.7 rhEPO Market Competitive Situation and Trends
2.7.1 rhEPO Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest rhEPO Players Market Share by Revenue
2.7.3 Global rhEPO Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 rhEPO Retrospective Market Scenario by Region
3.1 Global rhEPO Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global rhEPO Global rhEPO Sales by Region: 2019-2030
3.2.1 Global rhEPO Sales by Region: 2019-2024
3.2.2 Global rhEPO Sales by Region: 2025-2030
3.3 Global rhEPO Global rhEPO Revenue by Region: 2019-2030
3.3.1 Global rhEPO Revenue by Region: 2019-2024
3.3.2 Global rhEPO Revenue by Region: 2025-2030
3.4 North America rhEPO Market Facts & Figures by Country
3.4.1 North America rhEPO Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America rhEPO Sales by Country (2019-2030)
3.4.3 North America rhEPO Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.4.6 Mexico
3.5 Europe rhEPO Market Facts & Figures by Country
3.5.1 Europe rhEPO Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe rhEPO Sales by Country (2019-2030)
3.5.3 Europe rhEPO Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific rhEPO Market Facts & Figures by Country
3.6.1 Asia Pacific rhEPO Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific rhEPO Sales by Country (2019-2030)
3.6.3 Asia Pacific rhEPO Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Indonesia
3.6.10 Thailand
3.6.11 Malaysia
3.6.12 Philippines
3.6.13 Vietnam
3.7 Latin America rhEPO Market Facts & Figures by Country
3.7.1 Latin America rhEPO Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America rhEPO Sales by Country (2019-2030)
3.7.3 Latin America rhEPO Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa rhEPO Market Facts & Figures by Country
3.8.1 Middle East and Africa rhEPO Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa rhEPO Sales by Country (2019-2030)
3.8.3 Middle East and Africa rhEPO Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global rhEPO Sales by Type (2019-2030)
4.1.1 Global rhEPO Sales by Type (2019-2024)
4.1.2 Global rhEPO Sales by Type (2025-2030)
4.1.3 Global rhEPO Sales Market Share by Type (2019-2030)
4.2 Global rhEPO Revenue by Type (2019-2030)
4.2.1 Global rhEPO Revenue by Type (2019-2024)
4.2.2 Global rhEPO Revenue by Type (2025-2030)
4.2.3 Global rhEPO Revenue Market Share by Type (2019-2030)
4.3 Global rhEPO Price by Type (2019-2030)
5 Segment by Application
5.1 Global rhEPO Sales by Application (2019-2030)
5.1.1 Global rhEPO Sales by Application (2019-2024)
5.1.2 Global rhEPO Sales by Application (2025-2030)
5.1.3 Global rhEPO Sales Market Share by Application (2019-2030)
5.2 Global rhEPO Revenue by Application (2019-2030)
5.2.1 Global rhEPO Revenue by Application (2019-2024)
5.2.2 Global rhEPO Revenue by Application (2025-2030)
5.2.3 Global rhEPO Revenue Market Share by Application (2019-2030)
5.3 Global rhEPO Price by Application (2019-2030)
6 Key Companies Profiled
6.1 3SBio
6.1.1 3SBio Corporation Information
6.1.2 3SBio Description and Business Overview
6.1.3 3SBio rhEPO Sales, Revenue and Gross Margin (2019-2024)
6.1.4 3SBio rhEPO Product Portfolio
6.1.5 3SBio Recent Developments/Updates
6.2 Shanghai Chemo
6.2.1 Shanghai Chemo Corporation Information
6.2.2 Shanghai Chemo Description and Business Overview
6.2.3 Shanghai Chemo rhEPO Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Shanghai Chemo rhEPO Product Portfolio
6.2.5 Shanghai Chemo Recent Developments/Updates
6.3 Chengdu Diao
6.3.1 Chengdu Diao Corporation Information
6.3.2 Chengdu Diao Description and Business Overview
6.3.3 Chengdu Diao rhEPO Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Chengdu Diao rhEPO Product Portfolio
6.3.5 Chengdu Diao Recent Developments/Updates
6.4 NCPC Genetech
6.4.1 NCPC Genetech Corporation Information
6.4.2 NCPC Genetech Description and Business Overview
6.4.3 NCPC Genetech rhEPO Sales, Revenue and Gross Margin (2019-2024)
6.4.4 NCPC Genetech rhEPO Product Portfolio
6.4.5 NCPC Genetech Recent Developments/Updates
6.5 Kyowa Hakko Kirin
6.5.1 Kyowa Hakko Kirin Corporation Information
6.5.2 Kyowa Hakko Kirin Description and Business Overview
6.5.3 Kyowa Hakko Kirin rhEPO Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Kyowa Hakko Kirin rhEPO Product Portfolio
6.5.5 Kyowa Hakko Kirin Recent Developments/Updates
6.6 Shandong Kexing
6.6.1 Shandong Kexing Corporation Information
6.6.2 Shandong Kexing Description and Business Overview
6.6.3 Shandong Kexing rhEPO Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Shandong Kexing rhEPO Product Portfolio
6.6.5 Shandong Kexing Recent Developments/Updates
6.7 Ahua Pharmaceutical
6.6.1 Ahua Pharmaceutical Corporation Information
6.6.2 Ahua Pharmaceutical Description and Business Overview
6.6.3 Ahua Pharmaceutical rhEPO Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Ahua Pharmaceutical rhEPO Product Portfolio
6.7.5 Ahua Pharmaceutical Recent Developments/Updates
6.8 Biosidus
6.8.1 Biosidus Corporation Information
6.8.2 Biosidus Description and Business Overview
6.8.3 Biosidus rhEPO Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Biosidus rhEPO Product Portfolio
6.8.5 Biosidus Recent Developments/Updates
6.9 Dragon Pharma
6.9.1 Dragon Pharma Corporation Information
6.9.2 Dragon Pharma Description and Business Overview
6.9.3 Dragon Pharma rhEPO Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Dragon Pharma rhEPO Product Portfolio
6.9.5 Dragon Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 rhEPO Industry Chain Analysis
7.2 rhEPO Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 rhEPO Production Mode & Process
7.4 rhEPO Sales and Marketing
7.4.1 rhEPO Sales Channels
7.4.2 rhEPO Distributors
7.5 rhEPO Customers
8 rhEPO Market Dynamics
8.1 rhEPO Industry Trends
8.2 rhEPO Market Drivers
8.3 rhEPO Market Challenges
8.4 rhEPO Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
